关键词: 高危前列腺增生, 经尿道双极等离子前列腺切除术

Abstract: 【Abstract】〓Objective〓To assess the clinical efficacy and safety of bipolar transurethral plasma kinetic resection of the prostate (TUPKP) for treatment of high risk patients with benign prostatic hyperplasia (BPH). Methods〓The clinical data of 97 symptomatic BPH patients who underwent transurethral enucleate resection of prostate (TUERP) and TUPKP were retrospectively analyzed. 51 cases and 46 cases were performed by the methods of TUERP and TUPKP respectively. Results〓The mean operation time was (51.3±22.1) min. The volume of blood loss was (62.4±16.2) mL. The mean weight of resected prostate glands was (66.3±18.5) g. The washing time after operation was (36.1±10.3) h; and the extubating time was (5.0±1.5) d. The international prostate symptom score (IPSS) decreased from 26.6±4.5 to 6.8±3.5.Quality of life decreased from 5.9±1.3 to 1.8±0.6, and all the differences were significant (P<0.01). Conclusion〓TUPKP were effective and safe to deal with the patients with BPH in high risk, but proper individual operation method (TUERP or TUPKP) should depend on the specific circumstances of the patients.

Key words: High-risk benign prostatic hyperplasia, Bipolar transurethral plasmakinetic prostate-ctomy